Elimination of the atherogenic effect of beta blocker propranolol by papaverine
Andrianova, I.V.; Rekhter, M.D.; Tertov, V.V.; Andreeva, E.R.; Mironov, A.A.; Orekhov, A.N.
Biulleten' Eksperimental'noi Biologii i Meditsiny 113(3): 273-275
1992
ISSN/ISBN: 0365-9615 PMID: 1421225 Document Number: 398710
Recently, the ability of beta-blockers to stimulate proliferative activity and induce lipid accumulation in cultured human aortic intimal cells has been demonstrated. Moreover, the addition of calcium antagonists completely blocked the increase in proliferative activity and abolished cholesterol accumulation caused by propranolol. In this study blood serum of rabbits treated with 20 mg of propranolol induced 2-fold cholesterol accumulation in mouse peritoneal macrophages. Papaverin did not influence this effect. In case of simultaneous administration of propranolol and papaverin rabbit serum did not exhibit the ability to accumulate intracellular lipids. Propranolol substantially stimulated the formation of myointimal thickening and neutral lipid accumulation in denuded rabbit aorta. Papaverin completely blocked the propranolol-produced atherogenic changes. The data suggest that in vitro and in vivo atherogenic effects of beta-blockers may be prevented by papaverin.